Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: Can BNP-guided therapy improve health-related quality of life, and do responders to BNP-guided heart failure treatment have improved health-related quality of life? Results from the UPSTEP study

Fig. 1

Flow chart of the patients in the UPSTEP-study. Conventionally treated (CTR group) and BNP group, BNP group divided into responders and non-responders. Responder defined as a patient with a BNP under 300 ng/l and/or a decrease in BNP of at least 40 percent in week 16 of follow-up, compared to study start

Back to article page